ResMed Inc. (NYSE:RMD) Q1 2026 Earnings Call Transcript October 30, 2025
ResMed Inc. beats earnings expectations. Reported EPS is $2.55, expectations were $2.51.
Operator: Hello, and welcome to the Q1 Fiscal Year 2026 ResMed Earnings Conference Call. My name is Kevin. I’ll be your operator for today’s call. [Operator Instructions] Also, please note, this conference call is being recorded. [Operator Instructions] Let me hand the call over to Salli Schwartz, ResMed’s Chief Investor Relations...
